NEWS
Clinical Trial Seeks Potential ARDS Treatment
| University Hospitals

For the more than 200,000 patients diagnosed every year with Acute Respiratory Distress Syndrome (ARDS), there are few treatment options. Anywhere from 30 to 50 percent of those diagnosed will die of the disease, according to the American Lung Association. ARDS is a severe form of lung injury, most frequently caused by sepsis, inhalation injuries, […]

Toronto Memory Program attacking Alzheimer’s from all sides
| Toronto.com

Developing a safe and effective treatment for Alzheimer’s has been an increasing focus of pharmaceutical research. But scientists trying to crack the code of this complex disease have sometimes felt trapped in a house of mirrors, following seemingly promising paths and intriguing clues that suddenly and inexplicably recede. The relentless drumbeat of drug failure after […]

Liquid Biopsy Platform Demonstrates High Diagnostic Capabilities In Early Stages of Nasopharyngeal Carcinoma
| Onco'Zine

Commercial-stage medical technology company Laboratory for Advanced Medicine (LAM) announced positive results from a new study that evaluated DNA methylation-based marker panel for early diagnosis of nasopharyngeal carcinoma (NPC). The data will be presented in an online only abstract as part of the annual meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago, Ill., May […]